Use of OP-1 (rhBMP-7) in posterolateral lumbar arthrodesis.
作者信息
Badhiwala Jetan H, Fehlings Michael G
机构信息
Division of Neurosurgery and Spinal Program, Department of Surgery, Krembil Neuroscience Center, Toronto Western Hospital, Toronto, Ontario, Canada.
出版信息
J Spine Surg. 2016 Dec;2(4):338-344. doi: 10.21037/jss.2016.12.02.
Abstract
摘要
相似文献
1
Use of OP-1 (rhBMP-7) in posterolateral lumbar arthrodesis.OP-1（重组人骨形态发生蛋白-7）在腰椎后外侧融合术中的应用。
J Spine Surg. 2016 Dec;2(4):338-344. doi: 10.21037/jss.2016.12.02.
2
The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study.OP-1（重组人骨形态发生蛋白-7）替代自体髂骨植骨用于腰椎后外侧融合术的安全性和有效性：一项长期（>4年）关键研究。
Spine (Phila Pa 1976). 2008 Dec 15;33(26):2850-62. doi: 10.1097/BRS.0b013e31818a314d.
3
Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study.OP-1 油灰（重组人骨形态发生蛋白-7）与自体髂骨移植用于腰椎后外侧融合术的比较：一项至少为期 2 年的随访初步研究。
Spine (Phila Pa 1976). 2005 Dec 15;30(24):2709-16. doi: 10.1097/01.brs.0000190812.08447.ba.
4
The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.富含血小板血浆和骨髓对小鼠腰椎后外侧融合联合骨形态发生蛋白的影响
J Bone Joint Surg Am. 2009 May;91(5):1199-206. doi: 10.2106/JBJS.G.01375.
5
A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis.一项评估OP-1骨糊（重组人骨形态发生蛋白-7）替代自体髂嵴骨用于退行性腰椎滑脱后路腰椎融合术的安全性和有效性的初步研究。
Spine (Phila Pa 1976). 2004 Sep 1;29(17):1885-92. doi: 10.1097/01.brs.0000137062.79201.98.
6
Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.非人灵长类动物椎板切除术后使用重组人骨形态发生蛋白2/羟基磷灰石-磷酸三钙行腰椎后外侧横突间脊柱融合术
Spine (Phila Pa 1976). 1999 Jun 15;24(12):1179-85. doi: 10.1097/00007632-199906150-00002.
7
Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report.rhBMP-2 用于后路腰椎融合术再手术的并发症：一项单一实践回顾性病例系列报告。
Spine J. 2013 Oct;13(10):1244-52. doi: 10.1016/j.spinee.2013.06.022. Epub 2013 Aug 22.
8
rhBMP-2 for posterolateral instrumented lumbar fusion: a multicenter prospective randomized controlled trial.rhBMP-2 用于后路器械固定腰椎融合术：一项多中心前瞻性随机对照临床试验。
Spine (Phila Pa 1976). 2013 Dec 1;38(25):2139-48. doi: 10.1097/BRS.0000000000000007.
9
Re: Vaccaro AR, Patel T, Fischgrund J, et al. A pilot study evaluating safety and efficacy of OP-1 putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 2004;29:1885-92.回复：瓦卡罗·A·R、帕特尔·T、菲施grund·J等人。一项关于评估OP-1骨糊（重组人骨形态发生蛋白-7）在退行性腰椎滑脱后路腰椎融合术中替代髂嵴自体骨移植的安全性和有效性的初步研究。《脊柱》2004年；29卷：1885 - 1892页。
Spine (Phila Pa 1976). 2006 Apr 1;31(7):851; author reply 851-2. doi: 10.1097/01.brs.0000206384.54812.66.
10
Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.可吸收胶原海绵上的重组人骨形态发生蛋白-2联合骨传导填充剂用于后路关节融合内固定术：一项前瞻性随机试验
J Bone Joint Surg Am. 2009 Jul;91(7):1604-13. doi: 10.2106/JBJS.G.01157.
本文引用的文献
1
OP-1 Compared with Iliac Crest Autograft in Instrumented Posterolateral Fusion: A Randomized, Multicenter Non-Inferiority Trial.OP-1与髂嵴自体骨移植用于器械辅助后外侧融合术的比较：一项随机、多中心非劣效性试验。
J Bone Joint Surg Am. 2016 Mar 16;98(6):441-8. doi: 10.2106/JBJS.O.00209.
2
Union Rate and Complications in Spine Fusion with Recombinant Human Bone Morphogenetic Protein-7: Systematic Review and Meta-Analysis.脊柱融合中使用重组人骨形态发生蛋白-7 的融合率和并发症：系统评价和荟萃分析。
Global Spine J. 2016 Mar;6(2):124-32. doi: 10.1055/s-0035-1557143. Epub 2015 Jul 14.
3
Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 9: lumbar fusion for stenosis with spondylolisthesis.腰椎退行性疾病融合手术操作指南更新。第 9 部分：伴有滑脱的狭窄性腰椎融合术。
J Neurosurg Spine. 2014 Jul;21(1):54-61. doi: 10.3171/2014.4.SPINE14274.
4
Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.重组人骨形态发生蛋白-2 用于脊柱融合的安全性和有效性：一项个体参与者数据的荟萃分析。
Ann Intern Med. 2013 Jun 18;158(12):877-89. doi: 10.7326/0003-4819-158-12-201306180-00005.
5
The performance of BMP-2 loaded TCP/HAP porous ceramics with a polyelectrolyte multilayer film coating.负载 BMP-2 的 TCP/HAP 多孔陶瓷的性能与聚电解质多层膜涂层。
Biomaterials. 2011 Oct;32(30):7543-54. doi: 10.1016/j.biomaterials.2011.06.062. Epub 2011 Jul 23.
6
A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.脊柱外科中重组人骨形态发生蛋白-2 试验的批判性评价：新出现的安全性问题和经验教训。
Spine J. 2011 Jun;11(6):471-91. doi: 10.1016/j.spinee.2011.04.023.
7
Effects of protein dose and delivery system on BMP-mediated bone regeneration.蛋白质剂量和输送系统对 BMP 介导的骨再生的影响。
Biomaterials. 2011 Aug;32(22):5241-51. doi: 10.1016/j.biomaterials.2011.03.063. Epub 2011 Apr 20.
8
Immunogenicity of osteogenic protein 1: results from a prospective, randomized, controlled, multicenter pivotal study of uninstrumented lumbar posterolateral fusion.成骨蛋白 1 的免疫原性：一项未行器械辅助的腰椎后路侧方融合术的前瞻性、随机、对照、多中心关键研究结果。
J Neurosurg Spine. 2010 Oct;13(4):484-93. doi: 10.3171/2010.4.SPINE09957.
9
Off-label use of bone morphogenetic proteins in the United States using administrative data.美国基于行政数据评估骨形态发生蛋白的标签外使用。
Spine (Phila Pa 1976). 2010 Sep 1;35(19):1794-800. doi: 10.1097/BRS.0b013e3181ecf6e4.
10
A prospective, randomized, controlled, multicenter study of osteogenic protein-1 in instrumented posterolateral fusions: report on safety and feasibility.一项前瞻性、随机、对照、多中心研究：骨形成蛋白-1 在器械化后路融合术中的应用：安全性和可行性报告。
Spine (Phila Pa 1976). 2010 May 20;35(12):1185-91. doi: 10.1097/BRS.0b013e3181d3cf28.
Zotero 插件